Document is current
Any future updates will be listed below
-
Authors
Arseni, Lavinia https://orcid.org/0000-0001-5312-5278
Sigismondo, Gianluca
Yazdanparast, Haniyeh
Hermansen, Johanne U. https://orcid.org/0000-0003-3830-2277
Mack, Norman
Ohl, Sibylle
Kalter, Verena
Iskar, Murat https://orcid.org/0000-0001-8603-4313
Kalxdorf, Mathias https://orcid.org/0000-0002-5266-0778
Friedel, Dennis
Rettel, Mandy https://orcid.org/0000-0002-8304-3385
Paul, Yashna https://orcid.org/0000-0002-2312-2954
Ringshausen, Ingo
Eldering, Eric https://orcid.org/0000-0003-0561-6640
Dubois, Julie
Kater, Arnon P. https://orcid.org/0000-0003-3190-1891
Zapatka, Marc https://orcid.org/0000-0001-8287-5967
Roessner, Philipp M.
Tausch, Eugen
Stilgenbauer, Stephan https://orcid.org/0000-0002-6830-9296
Dietrich, Sascha https://orcid.org/0000-0002-0648-1832
Savitski, Mikhail M. https://orcid.org/0000-0003-2011-9247
Skånland, Sigrid S. https://orcid.org/0000-0003-1630-356X
Krijgsveld, Jeroen
Lichter, Peter
Seiffert, Martina https://orcid.org/0000-0001-5155-663X
-
Funding
Funding for this research was provided by:
José Carreras Leukämie-Stiftung (03 R/2021)
- License Information
-
More Information
Article History
Received: 19 June 2023
Accepted: 15 January 2025
First Online: 26 January 2025
Competing interests
: S.S.S. has received honoraria from AbbVie, AstraZeneca, BeiGene, and Janssen, and research support from BeiGene and TG Therapeutics outside of this work. E.T. has received honoraria from Abbvie, Janssen, AstraZeneca, BeiGene and research support by Abbvie, Hofmann-La Roche and Janssen-Cilag. StSt has received advisory board honoraria, research support, travel support, speaker fees from AbbVie, AstraZeneca, BeiGene, BMS, Gilead, GSK, Hoffmann-La Roche, Janssen, Novartis, and Sunesis. JD has received research funding from Roche/Genentech. MS has received advisory board honoraria from AbbVie and research support from Bayer AG. The remaining authors declare no competing interests.
